Gastro-Intestinal Committee


The Gastrointestinal Committee strives to:

  • Assist in the planning of the annual meeting scientific program and the review of submitted abstracts in the Solid Organ Targeted Therapy- Pre-clinical/Clinical Studies category.
  • Review the status of the Gastroenterology field and compile a list of major scientific issues that must be addressed to advance or enable cellular therapies.
  • Publish position papers and engage scientific discourse as necessary to advance the field.


Projects and Objectives

  • Contribute to the ISCT Annual Meeting program.
  • Prepare a consensus paper defining clinical trial criteria for mesenchymal stem cell treatments in immune-mediated intestinal diseases (i.e Crohn’s disease, ulcerative colitis, celiac disease)


Committee Members:

Rachele Ciccocioppo, MD
Co-Chair (Jan 2018 – Dec 2019)
University of Verona
Verona, Italy

Giuseppe Orlando, MD, PhD
Co-Chair (Jan 2018 – Dec 2019)
Wake Forest University
Winston-Salem, NC, USA



Basak Uygun, PhD
Harvard Medical School
Boston, MA, United States

Khalil N. Bitar, PhD
Wake Forest Institute for Regenerative Medicine
Winston Salem, NC, United States

Alejandro Soto-Gutiérrez, MD, PhD
University of Pittsburgh
Pittsburgh, PA, United States

Paolo De Coppi, MD, PhD
National Institute for Health Research
London, United Kingdom

Daniel C. Baumgart, MD, PhD, MBA, FRCP
University of Alberta
Edmonton, AB, Canada

Daniel Leffler, MD, MS
Takeda Pharmaceutical Company Ltd.
Boston, MA, United States

Claudia Dos Santos, MD, MSc
University of Toronto
Toronto, ON, Canada

Francesco Dazzi, MD
King’s College London
London, United Kingdom


© 2019 ISCT. All rights reserved. 
ISCT, and the ISCT logo are registered service marks of the International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of the International Society for Cellular Therapy.

ISCT Privacy Policy